Kura Oncology
Price & Volume
Stats
See moreOpen | $8.71 |
Previous Close | $8.67 |
Day Range | $8.64-$8.97 |
52W Range | $5.45-$12.49 |
Market Cap | $765.8M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $67.4M |
Revenue Growth (YoY) | -67.8% |
Gross Profit (12 Mos) | -$183.6M |
Diluted EPS | -$3.18 |
News
See moreYahoo Finance • 4 days ago
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Yahoo Finance • 14 days ago
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Yahoo Finance • last month
Kura Oncology GAAP EPS of -$0.92 misses by $0.18, revenue of $17.34M misses by $18.11M
Yahoo Finance • 2 months ago
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion
About
CEO | Dr. Troy Edward Wilson J.D., Ph.D. |
Address | 4930 Directors Place, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 260 |
